Differential regulation and properties of MAPKs

Adachi M, Fukuda M, Nishida E . (2000). Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol 148: 849–856.

Aguirre V, Uchida T, Yenush L, Davis R, White MF . (2000). The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047–9054.

Alarcon-Vargas D, Ronai Z . (2004). c-Jun-NH2 kinase (JNK) contributes to the regulation of c-Myc protein stability. J Biol Chem 279: 5008–5016.

Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A et al. (2004). Protein tyrosine phosphatases in the human genome. Cell 117: 699–711.

Aoyama K, Nagata M, Oshima K, Matsuda T, Aoki N . (2001). Molecular cloning and characterization of a novel dual specificity phosphatase, LMW-DSP2, that lacks the cdc25 homology domain. J Biol Chem 276: 27575–27583.

Aplin AE, Hogan BP, Tomeu J, Juliano RL . (2002). Cell adhesion differentially regulates the nucleocytoplasmic distribution of active MAP kinases. J Cell Sci 115: 2781–2790.

Arnette D, Gibson TB, Lawrence MC, January B, Khoo S, McGlynn K et al. (2003). Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J Biol Chem 278: 32517–32525.

Babu GR, Jin I W, Norman L, Waterfield M, Chang M, Wu X et al. (2006). Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: Implications for a novel mechanism of Tpl2 regulation. Biochim Biophys Acta 1763: 174–181.

Barsyte-Lovejoy D, Galanis A, Sharrocks AD . (2002). Specificity determinants in MAPK signaling to transcription factors. J Biol Chem 277: 9896–9903.

Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ . (1998). Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8: 1049–1057.

Bonny C, Nicod P, Waeber G . (1998). IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J Biol Chem 273: 1843–1846.

Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y et al. (2003). Mechanism of p38 MAP kinase activation in vivo. Genes Dev 17: 1969–1978.

Buchsbaum RJ, Connolly BA, Feig LA . (2002). Interaction of Rac exchange factors Tiam1 and Ras-GRF1 with a scaffold for the p38 mitogen-activated protein kinase cascade. Mol Cell Biol 22: 4073–4085.

Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O et al. (2001). Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411: 102–107.

Chang CI, Xu B, Akella R, Cobb MH, Goldsmith EJ . (2002). Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol Cell 9: 1241–1249.

Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B et al. (2001). MAP kinases. Chem Rev 101: 2449–2476.

Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM et al. (2006). Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 103: 2274–2279.

Chiariello M, Marinissen MJ, Gutkind JS . (2000). Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol Cell Biol 20: 1747–1758.

Chinkers M . (2001). Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab 12: 28–32.

Cho J, Tsichlis PN . (2005). Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide. Proc Natl Acad Sci USA 102: 2350–2355.

Conrad PW, Freeman TL, Beitner-Johnson D, Millhorn DE . (1999). EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem 274: 33709–33713.

Conrad PW, Millhorn DE, Beitner-Johnson D . (2000). Hypoxia differentially regulates the mitogen- and stress-activated protein kinases. Role of Ca2+/CaM in the activation of MAPK and p38 gamma. Adv Exp Med Biol 475: 293–302.

Court NW, dos Remedios CG, Cordell J, Bogoyevitch MA . (2002). Cardiac expression and subcellular localization of the p38 mitogen-activated protein kinase member, stress-activated protein kinase-3 (SAPK3). J Mol Cell Cardiol 34: 413–426.

Cuevas BD, Uhlik MT, Garrington TP, Johnson GL . (2005). MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability. Oncogene 23: 801–809.

Das S, Cho J, Lambertz I, Kelliher MA, Eliopoulos AG, Du K et al. (2005). Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner. J Biol Chem 280: 23748–23757.

Dougherty MK, Muller J, Ritt DA, Zhou M, Zhou XZ, Copeland TD et al. (2005). Regulation of raf-1 by direct feedback phosphorylation. Mol Cell 17: 215–224.

Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH et al. (2000). TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071–1083.

Efimova T, Broome AM, Eckert RL . (2003). A regulatory role for p38delta MAPK in keratinocyte differentiation: Evidence for p38delta - ERK1/2 complex formation. J Biol Chem 278: 34277–34285.

Efimova T, Deucher A, Kuroki T, Ohba M, Eckert RL . (2002). Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38 delta mitogen-activated protein kinase cascade that targets CCAAT/enhancer-binding protein alpha. J Biol Chem 277: 31753–31760.

Elion EA . (2001). The Ste5p scaffold. J Cell Sci 114: 3967–3978.

Enslen H, Raingeaud J, Davis RJ . (1998). Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 273: 1741–1748.

Faccio L, Chen A, Fusco C, Martinotti S, Bonventre JV, Zervos AS . (2000). Mxi2, a splice variant of p38 stress-activated kinase, is a distal nephron protein regulated with kidney ischemia. Am J Physiol Cell Physiol 278: C781–C790.

Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B et al. (2001). PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 1: 239–250.

Frantz B, Klatt T, Pang M, Parsons J, Rolando A, Williams H et al. (1998). The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 37: 13846–13853.

Furuchi T, Anderson RG . (1998). Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 273: 21099–21104.

Ganiatsas S, Kwee L, Fujiwara Y, Perkins A, Ikeda T, Labow MA et al. (1998). SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci USA 95: 6881–6886.

Heo YS, Kim SK, Seo CI, Kim YK, Sung BJ, Lee HS et al. (2004). Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J 23: 2185–2195.

Hibi M, Lin A, Smeal T, Minden A, Karin M . (1993). Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135–2148.

Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K et al. (2002). A central role for JNK in obesity and insulin resistance. Nature 420: 333–336.

Horiuchi D, Barkus RV, Pilling AD, Gassman A, Saxton WM . (2005). APLIP1, a kinesin binding JIP-1/JNK scaffold protein, influences the axonal transport of both vesicles and mitochondria in Drosophila. Curr Biol 15: 2137–2141.

Hu JH, Chen T, Zhuang ZH, Kong L, Yu MC, Liu Y et al. (2006). Feedback control of MKP-1 expression by p38. Cell Signal 19: 393–400.

Hu MC, Wang YP, Mikhail A, Qiu WR, Tan TH . (1999). Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines. J Biol Chem 274: 7095–7102.

Ishibe S, Joly D, Liu ZX, Cantley LG . (2004). Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol Cell 16: 257–267.

Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K et al. (1999). JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol Cell Biol 19: 7539–7548.

Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K . (1999). Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 13: 163–175.

Jesch SA, Lewis TS, Ahn NG, Linstedt AD . (2001). Mitotic phosphorylation of Golgi reassembly stacking protein 55 by mitogen-activated protein kinase ERK2. Mol Biol Cell 12: 1811–1817.

Johnson GL, Lapadat R . (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911–1912.

Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN . (2005). JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry 44: 14090–14096.

Kelkar N, Gupta S, Dickens M, Davis RJ . (2000). Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol Cell Biol 20: 1030–1043.

Kelkar N, Standen CL, Davis RJ . (2005). Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol Cell Biol 25: 2733–2743.

Kolch W . (2005). Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6: 827–837.

Kyriakis JM, Avruch J . (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807–869.

Lawler S, Fleming Y, Goedert M, Cohen P . (1998). Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr Biol 8: 1387–1390.

Lee CM, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP . (2002). JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci USA 99: 14189–14194.

Lee JC, Laydon JT, Mcdonnell PC, Gallagher TF, Kumar S, Green D et al. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739–746.

Letourneux C, Rocher G, Porteu F . (2006). B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J 25: 727–738.

Lewis TS, Shapiro PS, Ahn NG . (1998). Signal transduction through MAP kinase cascades. Adv Cancer Res 74: 49–139.

Lu G, Kang YJ, Han J, Herschman HR, Stefani E, Wang Y . (2006). TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling. J Biol Chem 281: 6087–6095.

Lu Z, Xu S, Joazeiro C, Cobb MH, Hunter T . (2002). The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol Cell 9: 945–956.

Luo W, Ng WW, Jin LH, Ye Z, Han J, Lin SC . (2003). Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation. J Biol Chem 278: 37451–37458.

Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL et al. (2001). Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 98: 2449–2454.

Manke IA, Nguyen A, Lim D, Stewart MQ, Elia AE, Yaffe MB . (2005). MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell 17: 37–48.

Marinissen MJ, Chiariello M, Gutkind JS . (2001). Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev 15: 535–553.

Matsubayashi Y, Fukuda M, Nishida E . (2001). Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells. J Biol Chem 276: 41755–41760.

Morrison DK, Davis RJ . (2003). Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 19: 91–118.

Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ et al. (2006). Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211–1214.

Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB et al. (1999). Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285: 1920–1923.

Parker CG, Hunt J, Diener K, McGinley M, Soriano B, Keesler GA et al. (1998). Identification of stathmin as a novel substrate for p38 delta. Biochem Biophys Res Commun 249: 791–796.

Paul S, Nairn AC, Wang P, Lombroso PJ . (2002). NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat Neurosci 6: 34–42.

Pearson GW, Earnest S, Cobb MH . (2006). Cyclic AMP selectively uncouples MAP kinase cascades from activating signals. Mol Cell Biol 26: 3039–3047.

Ranganathan A, Yazicioglu MN, Cobb MH . (2006). The nuclear localization of ERK2 occurs by mechanisms both independent of and dependent on energy. J Biol Chem 281: 15645–15652.

Rapp UR, Gotz R, Albert S . (2006). BuCy RAFs drive cells into MEK addiction. Cancer Cell 9: 9–12.

Rasar M, DeFranco DB, Hammes SR . (2006). Paxillin regulates steroid-triggered meiotic resumption in oocytes by enhancing an all-or-none positive-feedback kinase loop. J Biol Chem 281: in press.

Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH . (1995). Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92: 8881–8885.

Robinson FL, Whitehurst AW, Raman M, Cobb MH . (2002). Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. J Biol Chem 277: 14844–14852.

Roy M, Li Z, Sacks DB . (2004). IQGAP1 binds ERK2 and modulates its activity. J Biol Chem 279: 17329–17337.

Rubinfeld H, Hanoch T, Seger R . (1999). Identification of a cytoplasmic-retention sequence in ERK2. J Biol Chem 274: 30349–30352.

Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M, Wagner EF . (2004). Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 15: 713–725.

Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T . (2006). Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 176: 1899–1907.

Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC . (1996). Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J 15: 817–826.

Sanz V, Arozarena I, Crespo P . (2000). Distinct carboxy-termini confer divergent characteristics to the mitogen-activated protein kinase p38alpha and its splice isoform Mxi2. FEBS Lett 474: 169–174.

Sanz-Moreno V, Casar B, Crespo P . (2003). p38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels. Mol Cell Biol 23: 3079–3090.

Saxena M, Mustelin T . (2000). Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin Immunol 12: 387–396.

Schoorlemmer J, Goldfarb M . (2002). Fibroblast growth factor homologous factors and the islet brain-2 scaffold protein regulate activation of a stress-activated protein kinase. J Biol Chem 277: 49111–49119.

Seternes OM, Johansen B, Hegge B, Johannessen M, Keyse SM, Moens U . (2002). Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress. Mol Cell Biol 22: 6931–6945.

Sharrocks AD, Yang SH, Galanis A . (2000). Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem Sci 25: 448–453.

Shaul YD, Seger R . (2006). ERK1c regulates Golgi fragmentation during mitosis. J Cell Biol 172: 885–897.

Sudo T, Yagasaki Y, Hama H, Watanabe N, Osada H . (2002). Exip, a new alternative splicing variant of p38 alpha, can induce an earlier onset of apoptosis in HeLa cells. Biochem Biophys Res Commun 291: 838–843.

Takekawa M, Tatebayashi K, Saito H . (2005). Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol Cell 18: 295–306.

Tanoue T, Adachi M, Moriguchi T, Nishida E . (2000). A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol 2: 110–116.

Tanoue T, Maeda R, Adachi M, Nishida E . (2001). Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J 20: 466–479.

Tapon N, Nagata K, Lamarche N, Hall A . (1998). A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways. EMBO J 17: 1395–1404.

Teis D, Wunderlich W, Huber LA . (2002). Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell 3: 803–814.

Torii S, Kusakabe M, Yamamoto T, Maekawa M, Nishida E . (2004). Sef is a spatial regulator for Ras/MAP kinase signaling. Dev Cell 7: 33–44.

Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ . (1999). The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol Cell Biol 19: 1569–1581.

Tsuda M, Seong KH, Aigaki T . (2006). POSH, a scaffold protein for JNK signaling, binds to ALG-2 and ALIX in Drosophila. FEBS Lett 580: 3296–3300.

Uhlik MT, Abell AN, Johnson NL, Sun W, Cuevas BD, Lobel-Rice KE et al. (2003). Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat Cell Biol 5: 1104–1110.

Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C et al. (2000). Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 20: 4543–4552.

Wang Z, Harkins PC, Ulevitch RJ, Han J, Cobb MH, Goldsmith EJ . (1997). The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution. Proc Natl Acad Sci USA 94: 2327–2332.

Whitehurst AW, Robinson FL, Moore MS, Cobb MH . (2004). The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J Biol Chem 279: 12840–12847.

Whitehurst AW, Wilsbacher JL, You Y, Luby-Phelps K, Moore MS, Cobb MH . (2002). ERK2 enters the nucleus by a carrier-independent mechanism. Proc Natl Acad Sci U S A 99: 7496–7501.

Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ . (1998). A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671–1674.

Wilson KP, Fitzgibbon MJ, Caron PR, Griffith JP, Chen W, McCaffrey PG et al. (1996). Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem 271: 27696–27700.

Witowsky JA, Johnson GL . (2003). Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. J Biol Chem 278: 1403–1406.

Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS et al. (2006). Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 4: 61–73.

Xia Y, Wu Z, Su B, Murray B, Karin M . (1998). JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes Dev 12: 3369–3381.

Xu S, Cobb MH . (1997). MEKK1 binds directly to the c-Jun N-terminal kinases stress-activated protein kinases. J Biol Chem 272: 32056–32060.

Xu Z, Kukekov NV, Greene LA . (2003). POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis. EMBO J 22: 252–261.

Yagasaki Y, Sudo T, Osada H . (2004). Exip, a splicing variant of p38alpha, participates in interleukin-1 receptor proximal complex and downregulates NF-kappaB pathway. FEBS Lett 575: 136–140.

Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Pelling JC et al. (2003). Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 63: 1983–1994.

Yoon S, Seger R . (2006). The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 24: 21–44.

Yung Y, Yao Z, Aebersold DM, Hanoch T, Seger R . (2001). Altered regulation of ERK1b by MEK1 and PTP-SL and modified Elk1 phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs. J Biol Chem 276: 35280–35289.

Zervos AS, Faccio L, Gatto JP, Kyriakis JM, Brent R . (1995). Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci USA 92: 10531–10534.

Zhang H, Shi X, Hampong M, Blanis L, Pelech S . (2001). Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J Biol Chem 276: 6905–6908.

Zhang J, Zhou B, Zheng CF, Zhang ZY . (2003). A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates. J Biol Chem 278: 29901–29912.

Zhang Y, Neo SY, Wang X, Han J, Lin SC . (1999). Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal Kinase/Stress-activated protein kinase through domains distinct from wnt signaling. J Biol Chem 274: 35247–35254.

Zhou B, Zhang J, Liu S, Reddy S, Wang F, Zhang ZY . (2006a). Mapping ERK2-MKP3 binding interfaces by hydrogen/deuterium exchange mass spectrometry. J Biol Chem 281: 38834–38844.

Zhou G, Boomer JS, Tan TH . (2004). Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1. J Biol Chem 279: 49551–49561.

Zhou T, Sun L, Humphreys J, Goldsmith EJ . (2006b). Docking interactions induce exposure of activation loop in the MAP kinase ERK2. Structure 14: 1011–1019.